• KM. VANDANA NEGI
• Dr. Prashant Mathur

Sexual dysfunction is general side effect of antidepressants, especially of selective serotonin reuptake inhibitor and serotonin nor-epinephrine reuptake inhibitor medications. It can have important effect on the person’s quality of life, relationships, self respect, and recovery and can lead to noncompliance with antidepressant treatment with a possible for relapse of symptoms. The study involved 100 patients to assess sexual side effects profile of antidepressant in female patients with depression. In this study we assess according to the FSFI questionnaire and compare between two groups in which first is >30 and second is <30 score of FSFI respectively. Then compare the mean and standard deviation between first and second groups respectively. After that the P-value of all domains observed significant. In this study it was found that antidepressant induced sexual dysfunction is mostly observed in the patient used selective serotonin reuptake inhibitors. Patients between the age group of 18-30 and 31-40 years have high incidence of antidepressant induced sexual dysfunction and the mostly dysfunction observed by the escitalopram drug and the result shows significant.

Sexual dysfunction, antidepressant, escitalopram, FSFI

"ANTIDEPRESSANT INDUCED SEXUAL DYSFUNCTION- A CROSS SECTIONAL STUDY", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 6, page no.402-414, June 2019, Available :http://www.jetir.org/papers/JETIR1906Q57.pdf

"ANTIDEPRESSANT INDUCED SEXUAL DYSFUNCTION- A CROSS SECTIONAL STUDY", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 6, page no. pp402-414, June 2019, Available at : http://www.jetir.org/papers/JETIR1906Q57.pdf